TGF-β is critical for maintaining immune tolerance and preventing autoimmunity; therefore, its chronic inhibition cause toxicities including autoimmune-like symptoms such as colitis, dermatitis and pneumonitis, which have been reported in clinical trials involving TGF-β inhibitors [114,115,116]. Here, TGFB1 is linked to Autoimmunity.